dpp 4 inhibitor glp 1 agonist DPP-4 inhibitors and GLP-1RAs: cardiovascular safety and benefits ddp4 and glp 1 Effects
Description
Diabetes 62 , 11311138 (2013)
[DOI] [PMC free article] [PubMed] [Google Scholar] 117.Jalleh RJ, Plummer MP, Marathe CS, et al
doi: 10.1210/en.2019-00450 [DOI] [PMC free article] [PubMed] [Google Scholar] 199
Semaglutide (Wegovy pill): An OASIS 4 phase 3 clinical trial found 13.6% average weight loss after 64 weeks in adults with obesity or overweight (without diabetes) taking 25 mg of oral Wegovy daily
High-protein, calorie-controlled diet The most fundamental alternative to any weight loss medication is dietary modification
GLP-1 improves adipose tissue glyoxalase activity and capillarization improving insulin sensitivity in type 2 diabetes
